Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

9.24
Delayed Data
As of 10:02am ET
 -0.03 / -0.32%
Today’s Change
6.90
Today|||52-Week Range
9.93
+7.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues60.8M60.5M61.7M66.1M
 
 
 
 
 
Cost of Goods Sold29.2M27.0M30.5M31.0M
 
 
 
 
 
Depreciation And Amortization6.0M6.2M5.7M5.6M
 
 
 
 
 
 
Operating ExpensesGross Income25.5M27.3M25.5M29.5M
 
 
 
 
 
General Expenses24.1M26.7M25.6M28.2M
 
 
 
 
 
Research And Development967.0K930.0K862.0K947.0K
 
 
 
 
 
Total Operating Expenses59.4M60.0M61.8M64.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.4M529.0K-115.0K1.3M
 
 
 
 
 
Extraordinary Charge0.00-3.5M0.000.00
 
 
Interest Expense On Debt1.5M5.5M1.4M1.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-73.0K-8.4M-1.5M-97.0K
 
 
 
 
 
Income Taxes-6.0K-2.2M-825.0K-54.0K
 
 
 
 
 
Preferred Dividend-5.6M-8.0M-2.6M-2.6M
 
 
 
 
 
Net Income-67.0K-6.2M-654.0K-43.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS78.1M78.5M78.7M79.4M
 
 
 
 
 
Shares To Calculate EPS Diluted78.1M78.5M78.7M79.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.18-$0.04-$0.03
 
 
 
 
 
EPS Diluted-$0.07-$0.18-$0.04-$0.03